Focused U/S surgery is safe, effective for fibroids

Article

Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a safe, effective way to significantly reduce symptoms in premenopausal women with uterine leiomyomas, according to the results of a multicenter clinical trial.

Magnetic resonance-guided focused ultrasound surgery (MRgFUS) is a safe, effective way to significantly reduce symptoms in premenopausal women with uterine leiomyomas, according to the results of a multicenter clinical trial.

Researchers found that of 109 women undergoing MRgFUS, 71% experienced at least a 10-point reduction in symptom severity score on the Uterine Fibroid Quality-of-Life Instrument at 6 months after the procedure and 51% of 82 women did so at 12 months. Symptoms were reduced on average 39% and 36% at 6 and 12 months, respectively.

No deaths, life-threatening events, or thromboembolic events occurred during the 6 months postsurgery. There were no unintended second procedures or separate interventional treatments provided. And no patients were discharged with a urinary catheter. Six percent of patients developed fever, and 5% had skin burns where hair removal was incomplete. Mean time to return to work after the procedure was 1 day.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Thomas McElrath, MD, PhD, highlights limitations of current preeclampsia guidelines | Image Credit: physiciandirectory.brighamandwomens.org.
Jane Varney, MD, discusses how a low FODMAP diet mediates gut symptoms caused by endometriosis | Image Credit: lens.monash.edu.
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.